Venture NAV Tracker / Private company
Pelthos Therapeutics, Inc.
Headquarters—
Founded—
Last known round—
Reported valuation—
Cross-fund comparison
Equity & warrant marks
One latest disclosed mark per fund.
| Fund | Fair value | Security / basis | Implied price / share | Mark age vs round | Methodology / filing |
|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corp | $201KMar 31, 2026 · source ↗ | warrantFair Value | $3.07Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | 10-Q 2026-03-31 ↗ |
Cross-fund comparison
Debt investments
One latest disclosed debt mark per fund.
| Fund | Security type / basis | Principal | Fair value | FV / principal | Rate | Maturity | Mark age vs round | Non-accrual |
|---|---|---|---|---|---|---|---|---|
| HRZNHorizon Technology Finance Corp | senior secured loanFair Value — Term Loan | $5MMar 31, 2026 · source ↗ | $4.9MMar 31, 2026 · source ↗ | 97.9%Mar 31, 2026 · source ↗ | Cash rate 10.50%; Index Prime; Margin 3.75%; Floor 10.50%; ETP 5.00%Mar 31, 2026 · source ↗ | Jan 31, 2031Mar 31, 2026 · source ↗ | —Mar 31, 2026 · source ↗ | NoMar 31, 2026 · source ↗ |
Historical marks
Reported fair value by fund
Each bar is a disclosed position-quarter.